132 related articles for article (PubMed ID: 1703049)
1. Peptide 53-78 of myelin P2 protein is a T cell epitope for the induction of experimental autoimmune neuritis.
Rostami A; Gregorian SK
Cell Immunol; 1991 Feb; 132(2):433-41. PubMed ID: 1703049
[TBL] [Abstract][Full Text] [Related]
2. Induction of severe experimental autoimmune neuritis with a synthetic peptide corresponding to the 53-78 amino acid sequence of the myelin P2 protein.
Rostami A; Gregorian SK; Brown MJ; Pleasure DE
J Neuroimmunol; 1990 Dec; 30(2-3):145-51. PubMed ID: 1699975
[TBL] [Abstract][Full Text] [Related]
3. New minimum length requirement for a T cell epitope for experimental allergic neuritis.
Olee T; Powell HC; Brostoff SW
J Neuroimmunol; 1990 May; 27(2-3):187-90. PubMed ID: 1692033
[TBL] [Abstract][Full Text] [Related]
4. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
[TBL] [Abstract][Full Text] [Related]
5. Transfer of experimental allergic neuritis with P2-reactive T-cell lines.
Rostami A; Burns JB; Brown MJ; Rosen J; Zweiman B; Lisak RP; Pleasure DE
Cell Immunol; 1985 Apr; 91(2):354-61. PubMed ID: 2581699
[TBL] [Abstract][Full Text] [Related]
6. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope.
Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443
[TBL] [Abstract][Full Text] [Related]
7. The passive transfer of severe allergic neuritis in Lewis rats with lymphoid cells preincubated with P2 protein.
Szymanska I; Ramwani J; Eylar EH
Cell Immunol; 1983 Dec; 82(2):422-5. PubMed ID: 6197195
[TBL] [Abstract][Full Text] [Related]
8. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines.
Linington C; Lassmann H; Ozawa K; Kosin S; Mongan L
Eur J Immunol; 1992 Jul; 22(7):1813-7. PubMed ID: 1378018
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of experimental allergic neuritis in the immune suppressed host.
Hahn AF; Feasby TE; Lovgren D; Wilkie L
Acta Neuropathol; 1993; 86(6):596-601. PubMed ID: 7508670
[TBL] [Abstract][Full Text] [Related]
10. A T cell epitope for experimental allergic neuritis.
Olee T; Powers JM; Brostoff SW
J Neuroimmunol; 1988 Aug; 19(1-2):167-73. PubMed ID: 2456303
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness to P2 of blood- and cauda equina-derived lymphocytes in experimental allergic neuritis in the Lewis rat: preliminary characterisation of a P2-specific cauda equina-derived T cell line.
Taylor WA; Hughes RA
J Neuroimmunol; 1988 Oct; 19(4):279-89. PubMed ID: 2459155
[TBL] [Abstract][Full Text] [Related]
12. Detection and quantification of antibodies to the extracellular domain of P0 during experimental allergic neuritis.
Archelos JJ; Roggenbuck K; Schneider-Schaulies J; Toyka KV; Hartung HP
J Neurol Sci; 1993 Jul; 117(1-2):197-205. PubMed ID: 7691994
[TBL] [Abstract][Full Text] [Related]
13. T cell vaccination does not induce resistance to experimental autoimmune neuritis.
Jung S; Schluesener HJ; Toyka K; Hartung HP
J Neuroimmunol; 1991 Dec; 35(1-3):1-11. PubMed ID: 1720130
[TBL] [Abstract][Full Text] [Related]
14. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
[TBL] [Abstract][Full Text] [Related]
15. Delayed-type hypersensitivity response in experimental autoimmune neuritis treated with peptide-coupled spleen cells.
Gregorian SK; Rostami A
J Neuroimmunol; 1994 Apr; 51(1):69-75. PubMed ID: 7512578
[TBL] [Abstract][Full Text] [Related]
16. Comparative histology of experimental allergic neuritis induced with minimum length neuritogenic peptides by adoptive transfer with sensitized cells or direct sensitization.
Powell HC; Olee T; Brostoff SW; Mizisin AP
J Neuropathol Exp Neurol; 1991 Sep; 50(5):658-74. PubMed ID: 1716669
[TBL] [Abstract][Full Text] [Related]
17. Synergy between antibody and P2-reactive T cells in experimental allergic neuritis.
Spies JM; Pollard JD; Bonner JG; Westland KW; McLeod JG
J Neuroimmunol; 1995 Mar; 57(1-2):77-84. PubMed ID: 7535792
[TBL] [Abstract][Full Text] [Related]
18. Effects of ganglioside administration on experimental autoimmune neuritis induced by peripheral nerve myelin or P2-specific T cell lines.
Zielasek J; Jung S; Schmidt B; Ritter G; Hartung HP; Toyka K
J Neuroimmunol; 1993 Mar; 43(1-2):103-11. PubMed ID: 7681443
[TBL] [Abstract][Full Text] [Related]
19. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81.
Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H
J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221
[TBL] [Abstract][Full Text] [Related]
20. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines.
Heininger K; Stoll G; Linington C; Toyka KV; Wekerle H
Ann Neurol; 1986 Jan; 19(1):44-9. PubMed ID: 2418761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
